Connecting you to content on EBSCOhost

Works matching AU Tell, Roger

Results: 4

1

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 10, p. 1061, doi. 10.1007/s00262-014-1575-2

By:

Poschke, Isabel;
Lövgren, Tanja;
Adamson, Lars;
Nyström, Maria;
Andersson, Emilia;
Hansson, Johan;
Tell, Roger;
Masucci, Giuseppe;
Kiessling, Rolf

Publication type:

Article

2

Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin.

Published in:

Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 31, doi. 10.1007/s00280-020-04173-2

By:

Taflin, Helena;
Odin, Elisabeth;
Carlsson, Göran;
Tell, Roger;
Gustavsson, Bengt;
Wettergren, Yvonne

Publication type:

Article

3

Folate‐Associated Gene Expression in Primary Tumors Is Associated With Tumor Response and Progression‐Free Survival of Patients With Metastatic Colorectal Cancer Undergoing 5‐FU/Leucovorin‐Based Combination Chemotherapy.

Published in:

Cancer Medicine, 2025, v. 14, n. 9, p. 1, doi. 10.1002/cam4.70895

By:

Odin, Elisabeth;
Carlsson, Göran;
Saksena, Pushpa;
Edsjö, Anders;
Di Cara, Alessandro;
Tell, Roger;
Gustavsson, Bengt;
Wettergren, Yvonne

Publication type:

Article

4

Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy.

Published in:

Head & Neck, 2003, v. 25, n. 4, p. 313, doi. 10.1002/hed.10199

By:

Friesland, Signe;
Kanter-Lewensohn, Lena;
Tell, Roger;
Munck-Wikland, Eva;
Lewensohn, Rolf;
Nilsson, Anders

Publication type:

Article